PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

Potential Financial Implications of Yesterday's Results, page-55

  1. 1,081 Posts.
    lightbulb Created with Sketch. 269
    Does seem a bit strange...
    Not with them anymore or not trying to advertise success to much while phase 3 ongoing due to placebo effect?
    Enlighten us.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.